Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-27
DOI
10.1038/s41416-018-0157-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
- (2018) Mandy Stanske et al. NEOPLASIA
- Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium
- (2017) Ilary Ruscito et al. EUROPEAN JOURNAL OF CANCER
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- Microvessel density as a prognostic factor in esophageal squamous cell cancer patients
- (2017) Guangzhi Ma et al. MEDICINE
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
- (2016) Panida Lertkiatmongkol et al. CURRENT OPINION IN HEMATOLOGY
- Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
- (2016) Sandrina Lambrechts et al. EUROPEAN JOURNAL OF CANCER
- Targeting the tumour microenvironment in ovarian cancer
- (2016) Jean M. Hansen et al. EUROPEAN JOURNAL OF CANCER
- Microvessel Density as a Prognostic Factor in Ovarian Cancer: a Systematic Review and Meta-analysis
- (2015) Lei He et al. Asian Pacific Journal of Cancer Prevention
- Bronchial fibroepithelial polyp: a clinico-radiologic, bronchoscopic, histopathological andin-situhybridisation study of 15 cases of a poorly recognised lesion
- (2015) Eleonora Casalini et al. Clinical Respiratory Journal
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: A meta-analysis of literature
- (2013) Min Yu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- An immunologist's guide to CD31 function in T-cells
- (2013) F. M. Marelli-Berg et al. JOURNAL OF CELL SCIENCE
- Vascular Permeability and Drug Delivery in Cancers
- (2013) Sandy Azzi et al. Frontiers in Oncology
- Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer
- (2012) Niyati J. Nadkarni et al. CANCER LETTERS
- Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer
- (2012) K Danza et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
- (2012) Jie Li et al. Journal of Hematology & Oncology
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Serous Carcinoma
- (2011) Julian A. Crasta et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation